OptimizeRx (OPRX) Change in Accured Expenses (2016 - 2026)
OptimizeRx's Change in Accured Expenses history spans 16 years, with the latest figure at $1.5 million for Q4 2025.
- On a quarterly basis, Change in Accured Expenses fell 52.1% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 220.42% increase, with the full-year FY2025 number at $3.4 million, up 220.42% from a year prior.
- Change in Accured Expenses hit $1.5 million in Q4 2025 for OptimizeRx, up from -$2.2 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for OPRX hit a ceiling of $3.3 million in Q2 2025 and a floor of -$2.2 million in Q3 2025.
- Historically, Change in Accured Expenses has averaged $295555.4 across 5 years, with a median of $303534.0 in 2021.
- Biggest five-year swings in Change in Accured Expenses: skyrocketed 6010.65% in 2023 and later crashed 933.33% in 2025.
- Tracing OPRX's Change in Accured Expenses over 5 years: stood at $536185.0 in 2021, then soared by 74.63% to $936323.0 in 2022, then decreased by 15.2% to $794000.0 in 2023, then skyrocketed by 284.13% to $3.0 million in 2024, then crashed by 52.1% to $1.5 million in 2025.
- Business Quant data shows Change in Accured Expenses for OPRX at $1.5 million in Q4 2025, -$2.2 million in Q3 2025, and $3.3 million in Q2 2025.